Sublingual Cobalamin (Cyanocobalamin/Methylcobalamin)
Treatment for Vitamin B12 Deficiency
Effectiveness
97%
Safety Score
90%
Clinical Trials
2
Participants
5K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
90
DangerousModerateSafe
Treatment Details
0
Sublingual Cobalamin (Cyanocobalamin/Methylcobalamin) Outcomes
for Vitamin B12 Deficiency
Efficacy Outcomes
Overall Effectiveness
+97%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
1 active trial recruiting for Sublingual Cobalamin (Cyanocobalamin/Methylcobalamin) in Vitamin B12 Deficiency
This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcting Early-onset Vitamin B12 Deficiency in Adult Patients Using Proton Pump Inhibitors (PPIs). The Primary Outcome is the Change in Serum Vitamin B12 Levels Over a 6-week
NCT06966856NOT YET RECRUITINGPHASE3
23 participants
INTERVENTIONAL
Started: Dec 30, 2026